Effect of prior bevacizumab therapy in patients with platinum-sensitive recurrent ovarian carcinoma (ROC) in the phase 3 study ARIEL3 Meeting Abstract


Authors: Oza, A.; Coleman, R. L.; Lorusso, D.; Aghajanian, C.; Oaknin, A.; Dean, A.; Colombo, N.; Weberpals, J. I.; Clamp, A.; Scambia, G.; Leary, A.; Holloway, R. W.; Amenedo Gancedo, M.; Fong, P. C.; Goh, J. C.; O'Malley, D. M.; Banerjee, S.; Goble, S.; Cameron, T.; Ledermann, J. A.
Abstract Title: Effect of prior bevacizumab therapy in patients with platinum-sensitive recurrent ovarian carcinoma (ROC) in the phase 3 study ARIEL3
Meeting Title: 17th Biennial Meeting of the International Gynecologic Cancer Society (IGCS)
Journal Title: International Journal of Gynecological Cancer
Volume: 28
Issue: Suppl. 2
Meeting Dates: 2018 Sept 14-16
Meeting Location: Kyoto, Japan
ISSN: 1048-891X
Publisher: Lippincott Williams & Wilkins  
Date Published: 2018-09-01
Start Page: 45
End Page: 46
Language: English
ACCESSION: WOS:000471152400036
PROVIDER: wos
PUBMED: 30212387
DOI: 10.1136/00009577-201809002-00001
Notes: Meeting Abstract: IGCS8-0758 -- Source: Wos
Altmetric Score
MSK Authors